Medical News |
- Anxiety foretells mood disorders in children of bipolar parents
- <i>nab</i>-paclitaxel promising for Japanese NSCLC patients
- Late radiotherapy ‘not inferior’ for patients
- Selective <i>ALK </i>inhibitor shows NSCLC promise
- <i>nab</i>-paclitaxel promising for Japanese NSCLC patients
- Late radiotherapy ‘not inferior’ for patients
- Selective <i>ALK </i>inhibitor shows NSCLC promise
- Anxiety foretells mood disorders in children of bipolar parents
- Mental illness may not account for crime
- Community pharmacists help optimize COPD treatment
- <i>nab</i>-paclitaxel promising for Japanese NSCLC patients
- Late radiotherapy ‘not inferior’ for patients
- Selective <i>ALK </i>inhibitor shows NSCLC promise
- Mental illness may not account for crime
- Surrogate biomarkers unable to predict asthma severity
| Anxiety foretells mood disorders in children of bipolar parents Posted: 29 May 2013 05:00 PM PDT Children from families in which one parent has a diagnosis of bipolar disorder who develop anxiety are at increased risk for developing mood disorders later in life, a study shows. |
| <i>nab</i>-paclitaxel promising for Japanese NSCLC patients Posted: 29 May 2013 05:00 PM PDT Phase III trial results support the use of albumin-bound paclitaxel plus carboplatin as a first-line treatment for Japanese patients with advanced non-small-cell lung cancer. |
| Late radiotherapy ‘not inferior’ for patients Posted: 29 May 2013 05:00 PM PDT Researchers have questioned the timing of thoracic radiotherapy for patients undergoing four cycles of chemotherapy for limited-disease small-cell lung cancer. |
| Selective <i>ALK </i>inhibitor shows NSCLC promise Posted: 29 May 2013 05:00 PM PDT Preliminary trial results suggest that a novel, highly selective ALK inhibitor may be effective for the treatment of advanced non-small-cell lung cancer in Japanese patients with the ALK rearrangement. |
| <i>nab</i>-paclitaxel promising for Japanese NSCLC patients Posted: 29 May 2013 05:00 PM PDT Phase III trial results support the use of albumin-bound paclitaxel plus carboplatin as a first-line treatment for Japanese patients with advanced non-small-cell lung cancer. |
| Late radiotherapy ‘not inferior’ for patients Posted: 29 May 2013 05:00 PM PDT Researchers have questioned the timing of thoracic radiotherapy for patients undergoing four cycles of chemotherapy for limited-disease small-cell lung cancer. |
| Selective <i>ALK </i>inhibitor shows NSCLC promise Posted: 29 May 2013 05:00 PM PDT Preliminary trial results suggest that a novel, highly selective ALK inhibitor may be effective for the treatment of advanced non-small-cell lung cancer in Japanese patients with the ALK rearrangement. |
| Anxiety foretells mood disorders in children of bipolar parents Posted: 29 May 2013 05:00 PM PDT Children from families in which one parent has a diagnosis of bipolar disorder who develop anxiety are at increased risk for developing mood disorders later in life, a study shows. |
| Mental illness may not account for crime Posted: 29 May 2013 05:00 PM PDT The improved clinical outcomes achieved with assertive specialized treatment of patients with first-episode psychosis does not lead to a reduction in their criminal offending, shows research. |
| Community pharmacists help optimize COPD treatment Posted: 29 May 2013 05:00 PM PDT Data from Japan show that the introduction of an educational program allowing community pharmacists to deliver inhaler technique training to patients with chronic obstructive pulmonary disease led to improved adherence and outcomes. |
| <i>nab</i>-paclitaxel promising for Japanese NSCLC patients Posted: 29 May 2013 05:00 PM PDT Phase III trial results support the use of albumin-bound paclitaxel plus carboplatin as a first-line treatment for Japanese patients with advanced non-small-cell lung cancer. |
| Late radiotherapy ‘not inferior’ for patients Posted: 29 May 2013 05:00 PM PDT Researchers have questioned the timing of thoracic radiotherapy for patients undergoing four cycles of chemotherapy for limited-disease small-cell lung cancer. |
| Selective <i>ALK </i>inhibitor shows NSCLC promise Posted: 29 May 2013 05:00 PM PDT Preliminary trial results suggest that a novel, highly selective ALK inhibitor may be effective for the treatment of advanced non-small-cell lung cancer in Japanese patients with the ALK rearrangement. |
| Mental illness may not account for crime Posted: 29 May 2013 05:00 PM PDT The improved clinical outcomes achieved with assertive specialized treatment of patients with first-episode psychosis does not lead to a reduction in their criminal offending, shows research. |
| Surrogate biomarkers unable to predict asthma severity Posted: 28 May 2013 05:00 PM PDT A study evaluating surrogate biomarkers of airway inflammation has failed to identify any that can predict sputum eosinophil and neutrophil percentages with sufficient accuracy in patients with asthma. |
| You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
| Google Inc., 20 West Kinzie, Chicago IL USA 60610 | |
No comments:
Post a Comment